Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces an NIH website transition and links to updates and FAQs, noting that NIH content may use both “Super Intelligence” and “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T22:29:02.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site’s footer revision identifier changed from v3.7.1 to v3.7.2. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-17T22:33:22.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The displayed site revision advances from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:05.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with a standard header and footer, replacing the expected study record content. This indicates restricted access to the requested resource.
    Difference
    0.5%
    Check dated 2026-09-26T22:04:41.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows the new revision label Revision: v3.7.0. A large set of previously visible terms—names of institutions and investigators, as well as study-related drugs and concepts—were removed, altering how the study is described and who is represented as involved.
    Difference
    19%
    Check dated 2026-09-19T21:59:24.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a newer version of the study entry. This appears to be an internal revision with no changes to the study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-29T19:34:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.